AMGN compared with ATRA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ATRAAtara Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ATRAAtara Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only ATRA 5

—FUJIFILM Diosynth Biotechnologies California, Inc. (FDB)unlistedsupplier

—Memorial Sloan Kettering Cancer Center (MSK)unlistedsupplier

—QIMR Berghoferunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—HCR Molag Fund L.P. (HCRx)unlistedcustomer

1 more · ATRA chain ›

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ATRAAtara Biotherapeutics, Inc.

7.89▼−0.88%· post 7.75

ClosedNov 6 '26

Mkt cap$79.0MRevenue$630,000Q2 FY26Revenue$121MFY25

Compare

ClosedNov 6 '26

AMGNAmgen Inc

ATRAAtara Biotherapeutics, Inc.

460.55▲+0.06%post 460.42

Price

7.89▼−0.88%post 7.75

$249.0B

Mkt cap

$79.0M

Q3 FY26$10.4B

Revenue

$630,000Q2 FY26

FY25$36.8B

Revenue

$121MFY25

AMGN460.55▲+0.06%vsATRA7.89▼−0.88%ClosedNov 6 '26